Laboratory of Experimental Virology, Department of Medical Microbiology, Centre of Infection and Immunity Amsterdam (CINIMA), Academic Medical Centre of the University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands.
Arch Virol. 2010 Dec;155(12):2017-22. doi: 10.1007/s00705-010-0806-x. Epub 2010 Sep 24.
Infection of cell cultures with cell-free virus isolated from HIV-infected patients is notoriously difficult and results in a loss of viral variation. Here, we describe viral sequences from PBMC, U87.CD4.CCR5 and U87.CD4.CXCR4 cell cultures and compare them to those from blood plasma from 12 patients from whom virus particles were isolated using CD44 MicroBeads. In both PBMC and U87.CD4.CCR5 cultures, 66% of the plasma viral strains were retrieved after culturing. In addition, coreceptor use was predicted based on the env-V3 sequence and tested in U87.CD4 cells expressing either CCR5 or CXCR4. Recovery was lower for the CXCR4-using viruses. Only 50% of the virus clusters predicted to use CXCR4 could be retrieved from cell cultures, while 71% of CCR5-using strains were found in U87.CCR5 cultures. Therefore, isolation of primary viruses with CD44 MicroBeads results in a good representation in cell culture of the in vivo divergence.
从感染 HIV 的患者中分离出的无细胞病毒感染细胞培养物是众所周知的困难,并且会导致病毒变异的丢失。在这里,我们描述了来自 PBMC、U87.CD4.CCR5 和 U87.CD4.CXCR4 细胞培养物的病毒序列,并将其与从使用 CD44 MicroBeads 分离病毒颗粒的 12 名患者的血浆中的病毒序列进行了比较。在 PBMC 和 U87.CD4.CCR5 培养物中,培养后可回收 66%的血浆病毒株。此外,根据 env-V3 序列预测了核心受体的使用,并在表达 CCR5 或 CXCR4 的 U87.CD4 细胞中进行了测试。使用 CXCR4 的病毒的回收率较低。只有从细胞培养物中回收了预测使用 CXCR4 的病毒簇的 50%,而在 U87.CCR5 培养物中发现了 71%的 CCR5 使用株。因此,使用 CD44 MicroBeads 分离原发性病毒可在细胞培养物中很好地代表体内的病毒多样性。